Company intelligence / Profile preview

OrbiMed

New York City, New York, United Statesorbimed.com ↗

Ownership: Private
Employees: ~130
Development stage: Other

Overview

OrbiMed is a leading global healthcare investment firm with over $17 billion under management. It invests across all stages of company development—from seed-stage startups to large public corporations—in biopharmaceuticals, medical devices, diagnostics, digital health and healthcare services. Its investments have led to over sixty new therapies reaching patients via its venture-backed companies. The firm's flexible approach includes public equity funds, private equity funds and royalty/credit financing solutions.

Therapeutic areas: ImmunologyOncologyRare Diseases
Modalities: Small moleculeMonoclonal antibodyGene therapyCell therapyRNA therapy/oligonucleotides
Industry: Investors

Partnerships

Investments and partnerships with hundreds of biotech/pharma/device/digital health firms globallyStrategic partnership with Nanotronics for AI-driven manufacturing optimization

Beyond the preview

Go deeper on OrbiMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OrbiMed.

Explore the full profile